Market Cap 54.68M
Revenue (ttm) 36.35M
Net Income (ttm) -28.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -78.43%
Debt to Equity Ratio 1.06
Volume 11,400
Avg Vol 109,698
Day's Range N/A - N/A
Shares Out 54.68M
Stochastic %K 19%
Beta 1.17
Analysts Strong Sell
Price Target $5.38

Latest News on CTSO

Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 10:31 PM EDT - 8 months ago

Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript


CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

Aug 13, 2024, 4:18 PM EDT - 8 months ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer


CytoSorbents Secures $20 Million Credit Facility

Jul 2, 2024, 7:00 AM EDT - 9 months ago

CytoSorbents Secures $20 Million Credit Facility


Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript

May 9, 2024, 11:01 PM EDT - 11 months ago

Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript


CytoSorbents Reports First Quarter 2024 Results

May 9, 2024, 4:17 PM EDT - 11 months ago

CytoSorbents Reports First Quarter 2024 Results


CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

Aug 14, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial


CytoSorbents Reports First Quarter 2023 Results

May 2, 2023, 4:15 PM EDT - 2 years ago

CytoSorbents Reports First Quarter 2023 Results